Target intelligence / Profile preview

Ubiquitin specific peptidase 32 pseudogene 3 (USP32P3)

Target
USP32P3
Molecular classification
Other (Pseudogene)
01

Overview

Ubiquitin specific peptidase 32 pseudogene 3 (USP32P3) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but is generally nonfunctional due to mutations that prevent it from encoding a protein. Pseudogenes like USP32P3 do not function as protein-coding genes and are not known to act as receptors, enzymes, or other canonical therapeutic targets. While some pseudogenes can have regulatory effects on gene expression, including acting as decoys for microRNAs or being processed into regulatory RNAs, there is no evidence that USP32P3 itself performs these functions, nor is it currently considered a biomarker or therapeutic target. USP32P3 shares sequence similarity with the protein-coding gene USP32 (ubiquitin specific peptidase 32), but does not produce a functional enzyme or protein. No drugs, mechanisms of action, or clinical safety concerns are associated with USP32P3.

02

Mechanism of action

None (for therapeutic drugs; pseudogenes do not encode active protein products)

03

Biological functions

May participate in gene regulation as a noncoding RNA, but no direct protein or enzymatic function; possible regulatory RNA or involvement in RNA interference, as with other pseudogenes
04

Disease associations

Other (Pseudogenes have been implicated in cancer and other diseases via RNA regulatory mechanisms, but there is no evidence USP32P3 specifically plays such a role)

Beyond the preview

Go deeper on Ubiquitin specific peptidase 32 pseudogene 3 (USP32P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 32 pseudogene 3 (USP32P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call